Artificial Tears Improve Tear Stability - Scorecard - MDSpire

Artificial Tears Improve Tear Stability

  • By

  • Conexiant News Staff

  • March 4, 2026

  • 3 min

Share

Clinical Scorecard: Artificial Tears Improve Tear Stability

At a Glance

CategoryDetail
ConditionDry eye disease associated with prolonged digital screen use
Key MechanismsReduced blink rate and disrupted tear film stability due to extended screen exposure
Target PopulationPatients aged 20 to 40 years with symptomatic dry eye disease and high daily screen exposure
Care SettingOutpatient ophthalmology or optometry clinics

Key Highlights

  • Preservative-free 0.5% carboxymethyl cellulose artificial tears used four times daily for 1 month improved tear film stability.
  • Mean noninvasive tear break-up time (NIBUT) increased from 6.52 to 7.89 seconds post-treatment.
  • Small increases in central corneal epithelial thickness (~0.86 μm) were observed, though clinical significance is uncertain.

Guideline-Based Recommendations

Diagnosis

  • Assess tear film stability using noninvasive tear break-up time (NIBUT) testing.
  • Evaluate corneal epithelial structure with Fourier-domain optical coherence tomography (OCT).
  • Consider patient history of prolonged daily screen exposure as a risk factor.

Management

  • Use preservative-free artificial tears containing 0.5% carboxymethyl cellulose four times daily.
  • Advise early intervention in patients with dry eye symptoms related to digital screen use.

Monitoring & Follow-up

  • Monitor changes in tear film stability via NIBUT over treatment course.
  • Observe corneal epithelial thickness changes with OCT, acknowledging limitations in measurement repeatability.

Risks

  • No adverse effects or conflicts of interest reported in the study.
  • Clinical significance of small epithelial thickness changes remains uncertain.

Patient & Prescribing Data

Adults aged 20-40 years with dry eye symptoms and high screen exposure (mean 6.3 hours/day).

Artificial tears improved tear film stability significantly after 1 month; small epithelial changes noted but require further study.

Clinical Best Practices

  • Recommend preservative-free artificial tears to minimize ocular surface irritation.
  • Encourage regular use (four times daily) for at least one month to observe benefits.
  • Consider patient age and screen exposure duration when evaluating treatment response.
  • Recognize limitations of single-arm studies and the need for longer-term follow-up.

Related Resources & Content

Original Source(s)

Related Content